Selected article for: "liver function and logistic regression analysis"

Author: Ghweil, Ali A; Hassan, Mohammed H; Khodeary, Ashraf; Mohamed, Ahmed Okasha; Mohammed, Haggagy Mansour; Abdelazez, Ahmed Alyan; Osman, Heba Ahmed; Bazeed, Shamardan Ezzeldin S
Title: Characteristics, Outcomes and Indicators of Severity for COVID-19 Among Sample of ESNA Quarantine Hospital’s Patients, Egypt: A Retrospective Study
  • Cord-id: ss8z8py5
  • Document date: 2020_7_17
  • ID: ss8z8py5
    Snippet: BACKGROUND: The risk factors, disease characteristics, severity, and mortality of COVID-19 are unclear, particularly in Egypt. OBJECTIVE: The objective was to analyze the patients’ characteristics, hematological, biochemical, and chest imaging findings among the cohort of patients with COVID-19 in Egypt and also to shed light on the predictors of COVID-19 severity. PATIENTS AND METHODS: A retrospective study was conducted on 66 patients with COVID-19 in Egypt. Medical history, imaging data (CT
    Document: BACKGROUND: The risk factors, disease characteristics, severity, and mortality of COVID-19 are unclear, particularly in Egypt. OBJECTIVE: The objective was to analyze the patients’ characteristics, hematological, biochemical, and chest imaging findings among the cohort of patients with COVID-19 in Egypt and also to shed light on the predictors of COVID-19 severity. PATIENTS AND METHODS: A retrospective study was conducted on 66 patients with COVID-19 in Egypt. Medical history, imaging data (CT chest findings), and measured hematological and biochemical parameters at diagnosis were recorded in the form of complete blood counts and differential counts; CRP, ESR, serum ferritin, creatinine, and liver function tests . Results of real-time reverse transcription-polymerase chain reaction (rRT-PCR) for detection of SARS-CoV-2 RNA at diagnosis and during follow up of these patients were also recorded. RESULTS: The study included 36 patients with mild to moderate COVID-19 and 30 patients with severe/critical infection. There was a significant older age among severe (62.6 years old ±10.1SD) than mild to moderate infection (55.5 ± 10.1) (p˂0.05). Fever, dry cough, dyspnea, and sore throat malaise were highly frequent among COVID-19 patients, while headache and diarrhea were the least frequently occurring manifestations. All included cases (30 patients, 100%) with severe COVID-19 showed crazy-paving appearance (in the form of reticular and/or interlobular septal thickening) with or without GGO. There were significantly lower mean values of WBCs, lymphocytic count, total protein, and albumin among the severely infected than those who had mild to moderate COVID-19 infection, p˂0.05 for all. Additionally, there were significantly higher mean values of CRP, ESR, ferritin, ALT, and AST among patients with severe/critical COVID-19 when compared with those having mild to moderate COVID-19, p˂0.05 for all. CONCLUSION: Among the studied demographic, clinical, hematological, biochemical, and imaging data, dyspnea, diabetes mellitus, lymphopenia, raised CRP, ESR, ferritin, ALT, AST, low albumin, and presence of CT chest findings could be considered as predictors for COVID-19 severity using binary logistic regression analysis.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver and acid test nucleic: 1, 2, 3, 4
    • abnormal liver and acute phase: 1
    • abnormal liver and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • abnormal liver and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • abnormal liver biochemistry and acid test nucleic: 1
    • abnormal liver biochemistry and acute respiratory syndrome: 1, 2, 3, 4, 5
    • absence presence and acid test nucleic: 1, 2
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and liver dysfunction: 1
    • absence presence and liver enzyme: 1, 2, 3
    • absorption stage and acute respiratory syndrome: 1, 2
    • acid test nucleic and acute phase: 1, 2, 3
    • acid test nucleic and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid test nucleic and liver dysfunction: 1, 2, 3, 4
    • acid test nucleic patient and acute respiratory syndrome: 1, 2
    • acute phase and liver dysfunction: 1, 2, 3, 4
    • acute phase and liver enzyme: 1, 2